CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Dynasil Corporation of America is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Dynasil Corporation of America
313 Washington St Ste 403
Phone: (617) 668-6855p:617 668-6855 NEWTON, MA  02458-1626  United States Ticker: DYSLDYSL

This company ceased filing statements with the SEC on 8/29/2019.

Business Summary
Dynasil Corporation of America is engaged in the development, marketing and manufacturing of detection, sensing and analysis technology and optical components, as well as contract research. The Company operates through three segments, including Contract Research, Optics and Biomedical. The Contract Research segment consists of the Radiation Monitoring Devices, Inc. (RMD) business unit. The Optics segment operates through four business units: Dynasil Fused Silica, Optometrics Corporation, Hilger Crystals, Ltd. and Evaporated Metal Films Corporation, which manufactures commercial products, including optical crystals for sensing in the security and medical imaging markets, as well as optical components, optical coatings and optical materials for scientific instrumentation and other applications. The Biomedical segment consists of a business unit, Dynasil Biomedical Corporation, a medical technology incubator, which owns rights to certain early-stage medical technologies.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
YesYes-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/20199/30/2018YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Financial Officer Holly A.Hicks 37 10/1/2019 10/1/2019
Vice President of Financial Integration Robert J.Bowdring 60 10/1/2019 3/1/2013
Lead Independent Director William K.Hagan 64 1/1/2013 7/30/2012
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
DichroTec Thin Films, LLC 465 Paul Road Rochester NY United States

Business Names
Business Name
DichroTec Thin Films, LLC
Dynasil Biomedical Corporation
DYSL
7 additional Business Names available in full report.

General Information
Number of Employees: 233 (As of 9/30/2013)
Outstanding Shares: 17,618,173 (As of 8/8/2019)
Shareholders: 1,260
Stock Exchange: OTC
Federal Tax Id: 221734088
Fax Number: (617) 668-6992
Email Address: info@dynasil.com


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, December 14, 2019